Deutsche Bank’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $276K | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $108K | Buy |
|
|||||
|
2024
Q2 | $82.2K | Sell |
|
|||||
|
2024
Q1 | $187K | Buy |
|
|||||
|
2023
Q4 | $95.8K | Sell |
|
|||||
|
2023
Q3 | $116K | Buy |
|
|||||
|
2023
Q2 | $192K | Sell |
|
|||||
|
2023
Q1 | $604K | Buy |
|
|||||
|
2022
Q4 | $500K | Buy |
|
|||||
|
2022
Q3 | $443K | Sell |
|
|||||
|
2022
Q2 | $463K | Sell |
|
|||||
|
2022
Q1 | $779K | Sell |
|
|||||
|
2021
Q4 | $3.15M | Sell |
|
|||||
|
2021
Q3 | $3.77M | Buy |
|
|||||
|
2021
Q2 | $2.8M | Sell |
|
|||||
|
2021
Q1 | $4.06M | Buy |
|
|||||
|
2020
Q4 | $2.93M | Buy |
|
|||||
|
2020
Q3 | $534K | Sell |
|
|||||
|
2020
Q2 | $7.13M | Sell |
|
|||||
|
2020
Q1 | $13.5M | Buy |
|
|||||
|
2019
Q4 | $7.9M | Buy |
|
|||||
|
2019
Q3 | $381K | Sell |
|
|||||
|
2019
Q2 | $697K | Sell |
|
|||||
|
2019
Q1 | $5.72M | Sell |
|
|||||
|
2018
Q4 | $5.44M | Sell |
|
|||||
|
2018
Q3 | $7.84M | Buy |
|
|||||
|
2018
Q2 | $7.5M | Sell |
|
|||||
|
2018
Q1 | $6.63M | Buy |
|
|||||
|
2017
Q4 | $2.2M | Buy |
|
|||||
|
2017
Q3 | $859K | Sell |
|
|||||
|
2017
Q2 | $676K | Sell |
|
|||||
|
2017
Q1 | $1.59M | Sell |
|
|||||
|
2016
Q4 | $2.16M | Sell |
|
|||||
|
2016
Q3 | $4.5M | Buy |
|
|||||
|
2016
Q2 | $2.77M | Buy |
|
|||||
|
2016
Q1 | $1.94M | Sell |
|
|||||
|
2015
Q4 | $4.41M | Buy |
|
|||||
|
2015
Q3 | $641K | Buy |
|
|||||
|
2015
Q2 | $639K | Buy |
|
|||||
|
2015
Q1 | $279K | Sell |
|
|||||
|
2014
Q4 | $4M | Buy |
|
|||||
|
2014
Q3 | $3.05M | Buy |
|
|||||
|
2014
Q2 | $1.23M | Buy |
|
|||||
|
2014
Q1 | $751K | Buy |
|
|||||
|
2013
Q4 | $73K | Sell |
|
|||||
|
2013
Q3 | $396K | Buy |
|
|||||
|
2013
Q2 | $296K | Buy |
|